Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.
暂无分享,去创建一个
Madhusudhan R. Papasani | M. Atchison | Arindam Basu | Michael Atchison | Arindam Basu | Kristina Zaprazna | Madhusudhan Papasani | Kristína Zápražná
[1] Yang Shi,et al. Endoplasmic Reticulum Stress Induction of the Grp78/BiP Promoter: Activating Mechanisms Mediated by YY1 and Its Interactive Chromatin Modifiers , 2005, Molecular and Cellular Biology.
[2] L. Bystrykh,et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. , 2006, Blood.
[3] M. Vidal,et al. Homeotic transformations of the axial skeleton of YY1 mutant mice and genetic interaction with the Polycomb group gene Ring1/Ring1A , 2006, Mechanisms of Development.
[4] Zhiping Weng,et al. Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1. , 2007, Genome research.
[5] S. Nishiguchi,et al. Polycomb Group Gene rae28 Is Required for Sustaining Activity of Hematopoietic Stem Cells , 2002, The Journal of experimental medicine.
[6] M. Atchison,et al. Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue , 2005, Journal of cellular biochemistry.
[7] M. Atchison,et al. Characterization of Functional Domains within the Multifunctional Transcription Factor, YY1 (*) , 1995, The Journal of Biological Chemistry.
[8] Qiang Yu,et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. , 2007, Genes & development.
[9] J. Radford,et al. YY1 expression predicts favourable outcome in follicular lymphoma , 2010, Journal of Clinical Pathology.
[10] A. Birve,et al. A 1-Megadalton ESC/E(Z) Complex from Drosophila That Contains Polycomblike and RPD3 , 2003, Molecular and Cellular Biology.
[11] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.
[12] J. Girton,et al. Novel embryonic and adult homeotic phenotypes are produced by pleiohomeotic mutations in Drosophila. , 1994, Developmental biology.
[13] G. Stein,et al. Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: The C‐terminus is a principal determinant for nuclear trafficking , 1998, Journal of cellular biochemistry.
[14] Y. Shi,et al. Multiple mechanisms of transcriptional repression by YY1 , 1997, Molecular and cellular biology.
[15] Isora V Sernandez,et al. Haploinsufficiency of Activation-Induced Deaminase for Antibody Diversification and Chromosome Translocations both In Vitro and In Vivo , 2008, PloS one.
[16] Reiko Shinkura,et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1 , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] Wen‐Ming Yang,et al. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] T. Kajiume,et al. Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. , 2004, Experimental hematology.
[19] M. Atchison,et al. PcG recruitment by the YY1 REPO domain can be mediated by Yaf2 , 2009, Journal of cellular biochemistry.
[20] P. Hokland,et al. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia , 2008, European journal of haematology.
[21] V. Pirrotta,et al. Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites , 2002, Cell.
[22] A. Otte,et al. Polycomb group protein complexes: do different complexes regulate distinct target genes? , 1999, Biochimica et biophysica acta.
[23] C. Meijer,et al. Polycomb-group genes as regulators of mammalian lymphopoiesis. , 2001, Trends in immunology.
[24] M. Lohuizen. Functional analysis of mouse Polycomb group genes , 1998, Cellular and Molecular Life Sciences CMLS.
[25] G. Castellano,et al. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression , 2010, Cell cycle.
[26] Jeannie T. Lee,et al. YY1 Tethers Xist RNA to the Inactive X Nucleation Center , 2011, Cell.
[27] Kristian Helin,et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. , 2007, Genes & development.
[28] G. Lyons,et al. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. , 2004, Genes & development.
[29] R. DePinho,et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.
[30] M. Murvai,et al. Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. , 2001, European journal of cancer.
[31] S. Saleque,et al. Yin Yang 1 Is a Lipopolysaccharide-Inducible Activator of the Murine 3′ Igh Enhancer, hs3 1 , 2003, The Journal of Immunology.
[32] M. van Lohuizen,et al. Polycomb repression: from cellular memory to cellular proliferation and cancer. , 2002, Biochimica et biophysica acta.
[33] M. West,et al. Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers , 2005, Clinical Cancer Research.
[34] E. Hurt,et al. Clinical significance of Polycomb gene expression in brain tumors , 2010, Molecular Cancer.
[35] T. Honjo,et al. Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.
[36] D. Ghosh,et al. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. , 2007, Cancer research.
[37] M. Atchison,et al. Identification of YY1 sequences necessary for association with the nuclear matrix and for transcriptional repression functions , 1998, Journal of cellular biochemistry.
[38] C. Pilarsky,et al. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. , 2004, Neoplasia.
[39] David Jung,et al. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. , 2006, Annual review of immunology.
[40] Hengbin Wang,et al. Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.
[41] K. Calame,et al. Yin-yang 1 activates the c-myc promoter , 1993, Molecular and cellular biology.
[42] A. Iwama,et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. , 2004, Immunity.
[43] E. Moran,et al. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. , 1995, Genes & development.
[44] M. Bucan,et al. Promoter features related to tissue specificity as measured by Shannon entropy , 2005, Genome Biology.
[45] P. Möller,et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.
[46] Matthew D. Smith,et al. p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb. , 2011, Cancer research.
[47] H. Mano,et al. Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy , 2011, Haematologica.
[48] K. Oestreich,et al. Accessibility control of V(D)J recombination. , 2006, Advances in immunology.
[49] F. Stubenrauch,et al. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. , 1994, The EMBO journal.
[50] F. Karch,et al. A conserved sequence motif in Polycomb-response elements. , 1998, Molecular cell.
[51] C. Andry,et al. Transcription factor YY1 expression in human gastrointestinal cancer cells. , 2009, International journal of oncology.
[52] Tapio Visakorpi,et al. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late‐stage prostate cancer , 2006, Genes, chromosomes & cancer.
[53] M. Majidi,et al. Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression. , 1996, Nucleic acids research.
[54] N. Bonini,et al. Transcription factor YY1 functions as a PcG protein in vivo , 2003, The EMBO journal.
[55] D. Reinberg,et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. , 2004, Genes & development.
[56] Alberto Martin,et al. AID and mismatch repair in antibody diversification , 2002, Nature Reviews Immunology.
[57] E. Seto,et al. Molecular Cloning and Functional Characterization of the Transcription Factor YY2* , 2004, Journal of Biological Chemistry.
[58] E. Jane,et al. The Drosophila Polycomb Group proteins ESC and E(Z) are present in a complex containing the histone-binding protein p55 and the histone deacetylase RPD3. , 2001, Development.
[59] C. Croce,et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells , 2008, The Journal of experimental medicine.
[60] B. Bonavida,et al. Involvement of the TNF-α autocrine–paracrine loop, via NF-κB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis , 2006 .
[61] J. Lear,et al. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. , 1996, Cancer research.
[62] M. Whiteley,et al. The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. , 1998, Molecular cell.
[63] M. Atchison,et al. YY1 DNA binding and PcG recruitment requires CtBP. , 2004, Genes & development.
[64] M. Atchison,et al. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[65] F. Stubenrauch,et al. Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers , 1994, International journal of cancer.
[66] D. Spandidos,et al. Yin Yang 1 expression in human tumors , 2010, Cell cycle.
[67] U. Thorsteinsdóttir,et al. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. , 1999, Genes & development.
[68] L. Stubbs,et al. YY1 as a controlling factor for the Peg3 and Gnas imprinted domains. , 2007, Genomics.
[69] Vasco M. Barreto,et al. Somatic Hypermutation Is Limited by CRM1-dependent Nuclear Export of Activation-induced Deaminase , 2004, The Journal of experimental medicine.
[70] G. Sauvageau,et al. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.
[71] D. Reinberg,et al. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. , 2002, Genes & development.
[72] M. Lohuizen,et al. Stem Cells and Cancer The Polycomb Connection , 2004, Cell.
[73] Anton Berns,et al. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.
[74] Yang Shi,et al. Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein , 1991, Cell.
[75] Yan-wei Lin,et al. Gene Silencing by the Polycomb Group Proteins and Associations With Cancer , 2011, Cancer investigation.
[76] Michael R. Green,et al. Inappropriate Gene Activation in FSHD A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle , 2002, Cell.
[77] V. Pirrotta,et al. Chromatin-silencing mechanisms in Drosophila maintain patterns of gene expression. , 1997, Trends in genetics : TIG.
[78] Yang Shi,et al. A YY1–INO80 complex regulates genomic stability through homologous recombination–based repair , 2007, Nature Structural &Molecular Biology.
[79] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.
[80] A. Gozdzicka-Jozefiak,et al. Intratype HPV16 sequence variation within LCR of isolates from asymptomatic carriers and cervical cancers. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[81] C. Napoli,et al. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of α3β1-integrin in tumour cells , 2007, Oncogene.
[82] Kristian Helin,et al. EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.
[83] Michel C Nussenzweig,et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. , 2008, Immunity.
[84] C. Cerni,et al. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc , 1998, Oncogene.
[85] D. Margolis,et al. Targeted Derepression of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Pyrrole-Imidazole Polyamides , 2002, Journal of Virology.
[86] Yang Shi,et al. Essential Dosage-Dependent Functions of the Transcription Factor Yin Yang 1 in Late Embryonic Development and Cell Cycle Progression , 2006, Molecular and Cellular Biology.
[87] D. Schatz,et al. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. , 2000, Annual review of immunology.
[88] Hui Wang,et al. RYBP stabilizes p53 by modulating MDM2 , 2009, EMBO reports.
[89] C. Napoli,et al. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. , 2008, Cancer research.
[90] E. Seto,et al. Adenovirus E1A proteins interact with the cellular YY1 transcription factor , 1995, Journal of virology.
[91] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[92] B. Bonavida,et al. Rituximab-Induced Inhibition of YY1 and Bcl-xL Expression in Ramos Non-Hodgkin’s Lymphoma Cell Line via Inhibition of NF-κB Activity: Role of YY1 and Bcl-xL in Fas Resistance and Chemoresistance, Respectively1 , 2005, The Journal of Immunology.
[93] Bernhard Lüscher,et al. Characterization of the Transcriptional Regulator YY1 , 1997, The Journal of Biological Chemistry.
[94] J. Min,et al. Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. , 2003, Genes & development.
[95] J. Simon,et al. Roles of the EZH2 histone methyltransferase in cancer epigenetics. , 2008, Mutation research.
[96] S. Grossman,et al. Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.
[97] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[98] Guangchao Sui,et al. The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy , 2009 .
[99] A. Otte,et al. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation , 1999, Nature Genetics.
[100] R. Hoffman,et al. Essential Role for Activation of the Polycomb Group (PcG) Protein Chromatin Silencing Pathway in Metastatic Prostate Cancer , 2006, Cell cycle.
[101] Techung Lee,et al. Proteolytic Regulation of the Zinc Finger Transcription Factor YY1, a Repressor of Muscle-restricted Gene Expression* , 1998, The Journal of Biological Chemistry.
[102] Yang Shi,et al. Targeted Disruption of Mouse Yin Yang 1 Transcription Factor Results in Peri-Implantation Lethality , 1999, Molecular and Cellular Biology.
[103] C. Napoli,et al. Expression of transcription factor Yin Yang 1 in human osteosarcomas. , 2006, European journal of cancer.
[104] E. Seto,et al. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.
[105] B Z Levi,et al. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus , 1992, Molecular and cellular biology.
[106] B. Bonavida,et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.
[107] D. Schatz,et al. Balancing AID and DNA repair during somatic hypermutation. , 2009, Trends in immunology.
[108] M. Lohuizen. The trithorax-group and polycomb-group chromatin modifiers: implications for disease. , 1999 .
[109] T. Magnuson,et al. Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond. , 1997, Trends in genetics : TIG.
[110] M. Lieber,et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.
[111] K. Rajewsky,et al. Yin Yang 1 is a critical regulator of B-cell development. , 2007, Genes & development.
[112] Y. Shi,et al. Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair. , 2001, Biochemical and biophysical research communications.
[113] M. Moriuchi,et al. YY1 Transcription Factor Down-regulates Expression of CCR5, a Major Coreceptor for HIV-1* , 2003, The Journal of Biological Chemistry.
[114] S. Horvath,et al. Expression of transcription factor Yin Yang 1 in prostate cancer. , 2005, International journal of oncology.
[115] V. Pirrotta,et al. PcG complexes and chromatin silencing. , 1997, Current opinion in genetics & development.
[116] E. Jennings,et al. DNA binding sites for the transcriptional activator/repressor YY1. , 1995, Nucleic acids research.
[117] L. Pasqualucci,et al. AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.
[118] G. Peters,et al. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.
[119] Thomas Tuschl,et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. , 2008, Immunity.
[120] K. Calame,et al. An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. , 1994, Nucleic acids research.
[121] P. Kang,et al. Interaction between YY1 and the Retinoblastoma Protein , 2001, The Journal of Biological Chemistry.
[122] I. Ovcharenko,et al. Identification of clustered YY1 binding sites in imprinting control regions. , 2006, Genome research.
[123] Youngchang Kim,et al. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. , 2003, Genes & development.
[124] K Kornfeld,et al. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.
[125] D. Margolis,et al. Counterregulation of Chromatin Deacetylation and Histone Deacetylase Occupancy at the Integrated Promoter of Human Immunodeficiency Virus Type 1 (HIV-1) by the HIV-1 Repressor YY1 and HIV-1 Activator Tat , 2002, Molecular and Cellular Biology.
[126] M. Busslinger,et al. Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene , 2005, Nature Immunology.
[127] Jeffrey T. Chang,et al. Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer , 2009, Molecular Cancer Research.
[128] L. Stubbs,et al. Rapid evolution of a recently retroposed transcription factor YY2 in mammalian genomes. , 2006, Genomics.
[129] Jeremy J. W. Chen,et al. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion , 2005, Oncogene.
[130] T. Lee,et al. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. , 1994, Oncogene.
[131] Roy Riblet,et al. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. , 2005, Genes & development.
[132] M. Atchison,et al. Polycomb recruitment to DNA in vivo by the YY1 REPO domain , 2006, Proceedings of the National Academy of Sciences.
[133] Brigitte Wild,et al. Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex , 2002, Cell.
[134] Jeannie T. Lee,et al. Identification of a Ctcf cofactor, Yy1, for the X chromosome binary switch. , 2007, Molecular cell.
[135] D. Margolis,et al. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production , 1994, Journal of virology.
[136] Y. Nakanuma,et al. The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma , 2008, Laboratory Investigation.
[137] B. Bonavida,et al. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis , 2005, Oncogene.
[138] J. Shaughnessy,et al. Leukaemia disease genes: large-scale cloning and pathway predictions , 1999, Nature Genetics.
[139] Thomas Shenk,et al. TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA , 1994, Cell.
[140] O. Halvorsen,et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[141] M. Watson,et al. Activation-induced Cytosine Deaminase (AID) Is Actively Exported out of the Nucleus but Retained by the Induction of DNA Breaks* , 2004, Journal of Biological Chemistry.
[142] J. Nevins,et al. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function , 2002, The EMBO journal.
[143] S. Morrison,et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.
[144] H. Bernard,et al. A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16. , 2003, Virology.
[145] C. Milstein,et al. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[146] T. Honjo,et al. Role of AID in tumorigenesis. , 2007, Advances in immunology.
[147] B. Bonavida,et al. Nitric Oxide Inhibits the Transcription Repressor Yin-Yang 1 Binding Activity at the Silencer Region of the Fas Promoter: A Pivotal Role for Nitric Oxide in the Up-Regulation of Fas Gene Expression in Human Tumor Cells1 , 2001, The Journal of Immunology.
[148] Ruud Delwel,et al. The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. , 2003, Blood.
[149] Ya-Li Yao,et al. Regulation of Transcription Factor YY1 by Acetylation and Deacetylation , 2001, Molecular and Cellular Biology.